首页> 外国专利> Compounds derived from substituted amides,Modulating the activity of the Enzyme 11 beta hydroxysteroid dehydrogenase Type I; Pharmaceutical Composition and use in the treatment of diseases such as metabolic syndromeDyslipidemia, insulin resistance, among others.

Compounds derived from substituted amides,Modulating the activity of the Enzyme 11 beta hydroxysteroid dehydrogenase Type I; Pharmaceutical Composition and use in the treatment of diseases such as metabolic syndromeDyslipidemia, insulin resistance, among others.

机译：衍生自取代酰胺的化合物，调节I型酶11β羟类固醇脱氢酶的活性;药物组合物及其在疾病例如代谢综合征中的应用血脂异常，胰岛素抵抗等。

页面导航

摘要
著录项
相似文献

摘要

Compounds derived from substituted amides, modulating the activity of the Enzyme 11 beta hydroxysteroid dehydrogenase Type I; Pharmaceutical Composition and use in the treatment of diseases,Such as metabolic syndrome, insulin resistance, dyslipidemia, among others.

机译：衍生自取代酰胺的化合物，可调节I型酶11β羟类固醇脱氢酶的活性;药物组合物及其在疾病中的用途，例如代谢综合征，胰岛素抵抗，血脂异常等。

著录项

公开/公告号CL2008001197A1

专利类型
公开/公告日2008-12-19

原文格式PDF
申请/专利权人 HIGH POINT PHARMACEUTICALSLLC;
展开▼

申请/专利号CL20080001197
发明设计人 ROSKILDE SOREN EBDRUP;LYNGBY HENRIK SUNE ANDERSEN.;
展开▼

申请日2008-04-24
分类号A61K31/16;A61P3/00;A61P3/06;A61P3/10;C07D221/22;
国家 CL
入库时间 2022-08-21 19:28:19

相似文献

专利
外文文献
中文文献